BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19787270)

  • 21. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
    Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
    Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
    Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
    Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
    J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro.
    Koronkiewicz M; Chilmonczyk Z; Kazimierczuk Z
    Anticancer Res; 2013 Nov; 33(11):4891-9. PubMed ID: 24222126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock.
    Kang NI; Yoon HY; Kim HA; Kim KJ; Han MK; Lee YR; Hwang PH; Soh BY; Shin SJ; Im SY; Lee HK
    J Immunol; 2011 Jun; 186(11):6625-32. PubMed ID: 21531890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward the rational design of protein kinase casein kinase-2 inhibitors.
    Sarno S; Moro S; Meggio F; Zagotto G; Dal Ben D; Ghisellini P; Battistutta R; Zanotti G; Pinna LA
    Pharmacol Ther; 2002; 93(2-3):159-68. PubMed ID: 12191608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole.
    Bretner M; Najda-Bernatowicz A; Łebska M; Muszyńska G; Kilanowicz A; Sapota A
    Mol Cell Biochem; 2008 Sep; 316(1-2):87-9. PubMed ID: 18548199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
    Wachter J; Neureiter D; Alinger B; Pichler M; Fuereder J; Oberdanner C; Di Fazio P; Ocker M; Berr F; Kiesslich T
    Int J Biol Sci; 2012; 8(1):15-29. PubMed ID: 22211101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
    Ruzzene M; Penzo D; Pinna LA
    Biochem J; 2002 May; 364(Pt 1):41-7. PubMed ID: 11988074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 inhibitors.
    Martínez R; Geronimo BD; Pastor M; Zapico JM; Coderch C; Panchuk R; Skorokhyd N; Maslyk M; Ramos A; de Pascual-Teresa B
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32218358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time schedule-dependent effect of the CK2 inhibitor TBB on PC-3 human prostate cancer cell viability.
    Orzechowska E; Kozłowska E; Staroń K; Trzcińska-Danielewicz J
    Oncol Rep; 2012 Jan; 27(1):281-5. PubMed ID: 21993828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
    Yang L; Tang L; Dai F; Meng G; Yin R; Xu X; Yao W
    Toxicology; 2017 Aug; 389():74-84. PubMed ID: 28743511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
    Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
    Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphoinositide 3-kinase induced activation and cytoskeletal translocation of protein kinase CK2 in protease activated receptor 1-stimulated platelets.
    Nakanishi K; Toyoda H; Tanaka S; Yamamoto H; Komada Y; Gabazza EC; Hayashi T; Suzuki K; Ido M
    Thromb Res; 2010 Dec; 126(6):511-6. PubMed ID: 21055793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkappaB kinase in embryonic hippocampal progenitor cells.
    Min YK; Park JH; Chong SA; Kim YS; Ahn YS; Seo JT; Bae YS; Chung KC
    J Neurosci Res; 2003 Mar; 71(5):689-700. PubMed ID: 12584727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase CK2 is involved in zinc homeostasis in breast and prostate cancer cells.
    Zaman MS; Johnson AJ; Petersingham G; Muench GW; Dong Q; Wu MJ
    Biometals; 2019 Dec; 32(6):861-873. PubMed ID: 31583500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.
    Gray GK; McFarland BC; Rowse AL; Gibson SA; Benveniste EN
    Oncotarget; 2014 Aug; 5(15):6484-96. PubMed ID: 25153725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.